dr. byrd on ibrutinib in cll
Published 11 years ago • 1.4K plays • Length 0:39Download video MP4
Download video MP3
Similar videos
-
1:20
dr. byrd provides an update on ibrutinib in cll
-
2:28
dr. john byrd on ibrutinib in cll
-
1:29
dr. byrd on ibrutinib's impact on treatment landscape in cll
-
1:09
dr. byrd on long-term safety data with ibrutinib in cll
-
0:57
dr. byrd on alacabrutinib's mechanism of action in cll
-
1:06
dr. byrd on combination strategies in cll
-
0:51
dr. byrd on impact of ibrutinib on patients with cll
-
0:48
dr. byrd on bruton's tyrosine kinase in chronic lymphocytic leukemia
-
2:52
first results of head-to-head acalabrutinib versus ibrutinib in cll
-
7:13
using ibrutinib in chronic lymphocytic leukemia (cll)
-
4:02
managing ibrutinib toxicity in cll
-
4:07
management of cll progression after ibrutinib
-
2:02
dr. john byrd summarizes the resonate study findings
-
1:36
dr. john byrd on challenges in cll
-
1:29
dr. james on update of ibrutinib for chronic lymphocytic leukemia
-
5:55
pharmacovigilance with ibrutinib in chronic lymphocytic leukemia
-
1:34
dr. byrd on updated resonate findings in cll
-
9:02
efficacy and future role of ibrutinib in cll and mcl
-
0:56
dr. chavez discusses ibrutinib plus venetoclax in cll